OCT 11, 2021 3:00 AM PDT

Different Cancer Types Metastasize to Specific Regions of the Brain

WRITTEN BY: Katie Kokolus

Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. When cancer metastasizes to a different organ, it retains similar features and characteristics of the cancer from the original site. For example, breast cancer may metastasize to the brain, but the metastatic cancer cells will resemble breast, not brain cancer cells. 

The process of metastatic growth is complex and requires a series of intricate steps.  First, cancer cells grow into healthy tissue surrounding the primary tumor.  The tumor cells then travel through nearby lymph nodes and blood vessels into other parts of the body.  The tumor cells eventually exit the blood vessels and invade surrounding tissue, where a new tumor begins to form.  As the tumor grows at the metastatic site, new blood vessels form, providing blood and nutrients for the new cancer to grow. 

Cancer can spread anywhere in the body, but the most common metastatic sites are the brain, bone, liver, and lung.  Additionally, each cancer type is associated with different metastatic sites. 

Reports indicate that brain metastasis occurs in about 20 – 45% of cancer patients.  Some primary cancer sites prone to brain metastasis are breast, kidney, lung, colorectal, and skin cancer.  The region of the brain where metastasis occurs is not well understood.  However, understanding the unique distribution of metastasis could significantly improve treatment planning and provide more effective therapeutic options for late-stage cancer patients.

A study recently published in the Journal of Neurosurgery made great strides towards correlating the exact location in the brain where metastasis occurs to specific primary cancers.  The study examined almost 1,000 patients with brain-metastatic melanoma, kidney, lung, breast, and colorectal cancers. 

The researchers performed a procedure called Gamma knife radiosurgery (GKRS).  GKRS is a minimally invasive technique often used to treat brain tumors. The specialized approach allows doctors to precisely measure the exact coordinates of a tumor in the brain.

The study showed that lung cancer and melanoma had a high probability of spreading to the frontal and temporal lobes of the brain.  Alternatively, breast, renal, and colon cancers more commonly metastasized to the brain's back end, including the cerebellum and brainstem.

Using this data, the research team also developed two distinct predictive mathematical models to estimate the precise location of brain metastases based on the primary tumor site.  The first model showed that different parts of the brain were more susceptible to metastatic spread from certain types of cancer.  The second model estimated the probability of each cancer type metastasizing to a specific region of the brain.  The models gave similar results when evaluating the likelihood of some regions of the brain developing primary cancer-specific metastatic spread.

The authors concluded that their models show that brain metastasis occurs in distinct regions of the brain depending on the original cancer site. They also indicate that the findings of this study could provide a predictive diagnostic tool that would enhance therapeutic strategies to prevent the growth of brain metastasis.

 

Sources: Metastatic cancerbrain metastasisJournal of Neurosurgery

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JAN 10, 2022
Cancer
Race May Impact Radiation Efficacy in Prostate Cancer Patients
JAN 10, 2022
Race May Impact Radiation Efficacy in Prostate Cancer Patients
Racial disparities exist between Black and White populations in many types of cancer.  Researchers actively investi ...
JAN 20, 2022
Cancer
New Links Between Prostate Cancer Therapy and Depression
JAN 20, 2022
New Links Between Prostate Cancer Therapy and Depression
According to 2021 estimates, prostate cancer will account for more than a quarter of the cancer diagnoses and over 10% o ...
FEB 04, 2022
Drug Discovery & Development
A microbiome-based therapy for cancer patients is a step closer to approval
FEB 04, 2022
A microbiome-based therapy for cancer patients is a step closer to approval
The French pharmaceutical company, MaaT Pharma, has announced positive data showing the effectiveness of ...
FEB 11, 2022
Cannabis Sciences
Customized Phytocannabinoid Profiles: A Novel Source of Precision Therapeutics for Specific Cancer Subtypes?
FEB 11, 2022
Customized Phytocannabinoid Profiles: A Novel Source of Precision Therapeutics for Specific Cancer Subtypes?
According to a recent study published in Oncotarget, cannabis extracts may harbor the potential to eventually be tailore ...
MAR 14, 2022
Cancer
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
MAR 14, 2022
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
Over the past decade, immunotherapy drugs known as immune checkpoint inhibitors have emerged as a promising an ...
APR 19, 2022
Health & Medicine
Microplastics Found in Human Lungs. Are They Dangerous?
APR 19, 2022
Microplastics Found in Human Lungs. Are They Dangerous?
Research out of Hull York Medical School in England found small plastic debris known as microplastics deep in the lungs ...
Loading Comments...